Chondrosarcoma — Trials

Chondrosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

73 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 10
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04553692	Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers	terminated	Phase 1	272	IGM Biosciences, Inc.INDUSTRY	5	Mar 28, 2025	clinicaltrials
NCT03670069	Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas	terminated	Phase 1	27	Fred Hutchinson Cancer CenterOTHER	1	May 8, 2024	clinicaltrials